- Arts & Literature
- Science & Technology
By Sarah-Louise Fernandez
Oxford University has specifically been given the money from the £180 million Biomedical Catalyst fund which is managed by the Medical Research Council and the Technology Strategy Board. The University will use the funding to establish a ‘pipeline’, through which novel discoveries made in science laboratories throughout the city can be brought to the point of clinical development and testing.
All 14 universities will have control over the allocation of funding to projects within their institution, allowing them flexibility to pursue the most promising translational research opportunities and respond to new opportunities.
There are numerous potential projects that the money could be used for at Oxford University, including work on flu vaccines, through obtaining better measures of immune responses, or developing techniques that monitor the interaction of drugs with important proteins that reside in cell membranes.
“They will give academic researchers the opportunity to generate enough evidence to leverage further investment from a variety of sources to progress the best ideas, helping to bridge the gap between discovery and development.”